Immune Checkpoint Molecules
Immune checkpoint molecules are crucial components of the immune system that regulate the intensity and duration of immune responses but have been usurped by cancer cells and pathogens to evade the immune system.
Immune checkpoint molecules are crucial components of the immune system that regulate the intensity and duration of immune responses but have been usurped by cancer cells and pathogens to evade the immune system.
Immune checkpoint molecules are primarily involved in controlling T cell activity, which is a central component of the adaptive immune system. T cells are essential for recognizing and eliminating infected or abnormal cells. However, to prevent uncontrolled immune responses and autoimmunity, there are checkpoints or regulatory mechanisms in place. NK cells also use immune checkpoint molecules and other inhibitory receptors to regulate their activity.
One of the well-known immune checkpoint pathways is the programmed cell death protein 1 (PD-1) pathway and its ligands, PD-L1 and PD-L2. When these ligands bind to PD-1 on the surface of T cells, it inhibits T-cell activation and function, suppressing the immune response. Immune cells can express a variety of additional checkpoint molecules that regulate T cell activity, including CTLA-4, BTLA, LAG-3, Tim-3, TIGIT, PVRIG (CD112R), and VISTA (B7-H5).
Immune checkpoint molecules are primarily involved in controlling T cell activity, which is a central component of the adaptive immune system. T cells are essential for recognizing and eliminating infected or abnormal cells. However, to prevent uncontrolled immune responses and autoimmunity, there are checkpoints or regulatory mechanisms in place. NK cells also use immune checkpoint molecules and other inhibitory receptors to regulate their activity.
One of the well-known immune checkpoint pathways is the programmed cell death protein 1 (PD-1) pathway and its ligands, PD-L1 and PD-L2. When these ligands bind to PD-1 on the surface of T cells, it inhibits T-cell activation and function, suppressing the immune response. Immune cells can express a variety of additional checkpoint molecules that regulate T cell activity, including CTLA-4, BTLA, LAG-3, Tim-3, TIGIT, PVRIG (CD112R), and VISTA (B7-H5).
Since cancer cells can exploit these checkpoint mechanisms to evade the immune system, immune checkpoint inhibitors (ICIs) have been developed as a form of immunotherapy to block these inhibitory signals, unleashing the immune system to target and destroy cancer cells more effectively. Antibody-based drugs targeting PD-1, PD-L1, and CTLA-4 have shown significant success in treating various cancers by enhancing the immune response against tumor cells. However, managing the side effects and understanding the broader implications of manipulating immune checkpoints remain active areas of research in the field of immunotherapy.
Comprehensive Solutions for Immune Checkpoint Inhibitor Research and Development
Recombinant Proteins
- Immune checkpoint molecules and ligands for in vitro ligand binding assays
- Human, Mouse, Monkey, & Woodchuck
- Multiple labels and tags available
- View Products
Cell Lines
- Reporter cells for co-culture assays to screen for inhibitors
- Immune checkpoint molecule or ligand-expressing cell lines
- View Products
Antibodies
- Neutralizing or agonistic antibodies targeting immune checkpoint molecules and ligands
- Biotin and PE conjugates available
- View Products
High-Titer Lentiviruses for Cell Engineering
- For expression of immune checkpoint molecules and ligands
- CRISPR/Cas9 lentiviruses for knocking out immune checkpoints and ligands
- View Products
Assay Kits
- Biochemical and cell-based assay kits to screen for inhibitors
- High throughput options available, including homogeneous assays in 384-well plates
- View Biochemical Assay Kits
- View Cell-Based Assay Kits
Screening & Profiling Services
Custom Product Development
Looking for custom products for your research project? We can help with that. Contact us or view our custom development options.
Product Results
Inquiries
│Products
│Related Services
- Custom Cell Line Development
- Immunotherapy Biochemical Screening & Profiling
- Immunotherapy Cell-Based Screening Services